Neuroscience

π Neuroscience π Digital

Generative AI: the risk of cognitive atrophy

Avec Ioan Roxin, Professor Emeritus at Marie et Louis Pasteur University

On July 3rd, 2025
6 min reading time

A study showed that 83% of AI users were unable to remember a passage they had just written for an essay. A look at the impact of AI on our brains.

π Society π Neuroscience

From dish to brain, how dopamine influences our behaviour

Avec Giuseppe Gangarossa, Professor of Neurobiology at Université Paris Cité

On May 21st, 2025
4 min reading time

Lipids may influence our reward system.

π Neuroscience π Health and biotech

How do our bodies tune into the Sun's rhythm?

Avec Claude Gronfier, Researcher in Chronobiology at Inserm's Centre de Recherche en Neurosciences de Lyon

On March 19th, 2025
4 min reading time

A study of RATP employees shows that tram and bus drivers (outdoors) have fewer sleep disorders than metro drivers (indoors).

π Neuroscience π Health and biotech

What effect do screens have on our sleep?

Avec Russel Foster , Director of the Sleep and Circadian Research Institute at the University of Oxford

On March 11th, 2025
5 min reading time

There are several preconceived ideas about the link between screens and sleep; studies need to be nuanced as they are often carried out in laboratories and not outdoors.

π Neuroscience π Health and biotech

What do we really know about our dreams?

Avec Delphine Oudiette, Inserm Research Director and Co-Director of DreamTeam at Institut du Cerveau in Paris, Claudia Picard-Deland, Postdoctoral Researcher in the Department of Psychiatry and Addictology at Université de Montréal

On March 5th, 2025
5 min reading time

The level of evidence in studies on dreams is generally low... So what do we know about our dreams today?

π Health and biotech π Neuroscience π Society

Down syndrome: can intellectual disability of patients be treated?

Avec Brigitte Fauroux , Professor of Pneumo-pediatrics at Necker Hospital, Laurent Meijer, Former CNRS Unit Director and Founder of start-up Perha Pharmaceuticals

On February 5th, 2025
4 min reading time

Today, research is looking into the possibility of treating the intellectual disability associated with Down's syndrome.